Synopsys Inc. filings document the regulatory record for a Nasdaq-listed engineering software company whose common stock trades under SNPS. The company’s disclosures cover operating and financial results, capital allocation actions such as stock repurchase authorizations and accelerated share repurchase agreements, and material-event reports tied to governance, executive roles, and organizational changes.
Proxy and annual meeting materials describe board elections, shareholder voting matters, executive compensation, equity incentive plan approvals, and corporate governance practices. Recent Form 8-K filings also document restructuring actions following the completed Ansys acquisition, amendments to prior governance disclosures, registered common stock details, exhibits, and risk-oriented statements associated with forward-looking business actions.
Synopsys, Inc. (SNPS) reported strong growth for the quarter ended July 31, 2026, with total revenue of $2.48 billion, up from $1.74 billion a year earlier, and net income attributed to Synopsys of $545.8 million versus $242.5 million. Diluted EPS from continuing operations rose to $2.84 from $1.50. Growth was driven by Design Automation revenue of $2.00 billion and Design IP revenue of $473.9 million, with Ansys-branded products contributing a rising share.
For the first nine months, revenue reached $7.16 billion compared with $4.80 billion, while net income declined to $627.3 million from $884.8 million, reflecting substantially higher $1.21 billion of acquired intangible amortization and $236.3 million in restructuring charges tied to a 2026 plan estimated at $425–500 million. Synopsys also recorded a $380.5 million net pre-tax gain on the sale of its Processor IP business.
Cash flow from operations for the nine months improved to $2.30 billion from $878.9 million, and cash, cash equivalents and restricted cash were $3.61 billion. The company carries $10.0 billion of Senior Notes outstanding after fully repaying a $4.3 billion term loan. Backlog (contracted but unsatisfied performance obligations) was about $10.9 billion, including $1.9 billion of non-cancellable FSA commitments.
SYNOPSYS, INC. (SNPS) filed an amendment to update its disclosure about a previously approved restructuring plan. The Board originally approved the restructuring plan on November 9, 2025, and on August 21, 2026, approved updated estimates reflecting higher restructuring costs.
Synopsys now estimates it will recognize pre-tax charges ranging from $425 million to $500 million to its GAAP financial results. These charges consist primarily of severance and other one-time termination benefits, as well as costs related to certain site closures as part of its global site strategy. The company characterizes these as forward-looking estimates subject to risks, including possible changes in the size, components and timing of the expected costs and Synopsys’ ability to realize the benefits of the restructuring.
Synopsys, Inc. (SNPS) reported strong third-quarter fiscal 2026 results, with revenue of $2.48 billion, up from $1.74 billion a year earlier. GAAP net income from continuing operations rose to $545.8 million ($2.84 per diluted share) from $242.5 million ($1.50 per share).
On a non-GAAP basis, net income from continuing operations increased to $752.5 million, or $3.91 per diluted share, from $548.9 million, or $3.39 per share. Design Automation generated $2.00 billion of Q3 revenue, while Design IP contributed $473.8 million. Non-GAAP operating margin reached 41.6%.
For the fourth quarter of fiscal 2026, Synopsys targets revenue of $2.53–$2.58 billion and non-GAAP EPS of $4.10–$4.16. For the full fiscal year 2026, it targets revenue of $9.69–$9.74 billion, non-GAAP operating margin of about 41.5%, non-GAAP EPS of $15.04–$15.10, operating cash flow of about $2.8 billion and free cash flow of about $2.6 billion.
Synopsys Inc. executive Janet Lee, GC & Corporate Secretary, reported the vesting and settlement of 729 Restricted Stock Units into 729 shares of common stock on 2026-08-16. In connection with this vesting, 318 shares of common stock were retained by the company at $421.50 per share to satisfy Ms. Lee’s tax withholding obligations, as approved by the Compensation Committee. Following the transaction, Ms. Lee held 4,374 restricted stock units, with no remaining derivative positions reported in this filing.
Synopsys, Inc. reported a leadership transition in its legal function. Janet Lee will cease serving as General Counsel and Corporate Secretary effective on the earlier of December 31, 2026 or the appointment of her successor. After her successor is in place, she will move into an advisory role to support continuity.
Synopsys states that Ms. Lee will continue in this advisory capacity until June 30, 2027, or a later date determined by the company, to help ensure a smooth transition of responsibilities. The filing does not describe any changes to Synopsys’ business operations beyond this leadership change.
Synopsys Inc. Chief Revenue Officer Michael Ellow reported routine equity compensation activity involving restricted stock units and related tax withholding. On 2026-06-15, 5,128 restricted stock units converted into an equal number of shares of common stock in two installments of 1,080 and 4,048 units.
To cover tax withholding obligations tied to this vesting, the company retained 2,543 shares at a price of $454.38 per share, as approved by the Compensation Committee. After these transactions, Ellow holds 2,041 shares of Synopsys common stock directly and 16 shares indirectly through a family trust, along with 26,713 remaining restricted stock units.
Synopsys Inc. general counsel and corporate secretary Janet Lee reported routine equity compensation activity involving restricted stock units. On 2026-06-15, 540 restricted stock units converted into 540 shares of common stock, reflecting a scheduled vesting.
On the same date, 235 common shares were withheld by Synopsys at a price of $454.38 per share to satisfy Ms. Lee’s tax withholding obligations, as approved by the Compensation Committee. After these transactions, she directly held 15,582 shares of common stock and 2,698 restricted stock units.
Synopsys deputy CFO and chief accounting officer Sudhindra Kankanwadi reported routine equity compensation activity involving restricted stock units. On June 15, 2026, 720 restricted stock units converted into 720 shares of Synopsys common stock as part of a scheduled vesting.
Of these shares, 249 were retained by Synopsys to cover the related tax withholding obligations, as approved by the Compensation Committee, leaving a net 471 shares effectively added to his directly held common stock. Following these transactions, he directly holds 22,690 shares of common stock and 3,597 restricted stock units.
Synopsys CFO Shelagh Glaser reported routine equity compensation activity involving restricted stock units. On June 15, 2026, 1,259 restricted stock units converted into the same number of shares of Synopsys common stock, reflecting a scheduled vesting event. In connection with this vesting, 436 shares of common stock were retained by Synopsys at a price of $454.38 per share to satisfy tax withholding obligations approved by the Compensation Committee, rather than being sold in the open market. Following these transactions, Glaser directly owned 1,452 shares of common stock and indirectly held 14,358 shares through a trust.
Synopsys Inc. director and president/CEO Ghazi Sassine exercised equity awards and sold shares in a pre-planned transaction. On 2026-06-15, he exercised options and restricted stock units to acquire a total of 17,913 shares of common stock, including 14,603 shares from non-qualified stock options at an exercise price of $135.88 per share and 3,310 shares from restricted stock units that convert one-for-one into common stock.
On the same date, he sold 14,603 shares of common stock in open-market transactions at a weighted average price of $458.962 per share under a Rule 10b5-1 trading plan adopted on September 19, 2025, and 1,492 shares were withheld by the company to cover tax obligations related to RSU vesting. Following these transactions, he holds 75,020 shares of Synopsys common stock directly.